Tag: reveal

Posted on by

Reuters Events Free Webinar: GM, VW and Hyundai Reveal Their Blueprint to Automotive’s Decade of Transformation

Reuters Events Free Webinar: GM, VW and Hyundai Reveal Their Blueprint to Automotive's Decade of Transformation

London, United Kingdom–(Newsfile Corp. – June 15, 2022) – The automotive industry is facing more disruption over the next few years than in the last 50 years, with governmental pressure to reduce emissions, growing concerns around vehicle safety and the demand for new, more customized experiences.

We have now progressed from the phase of innovation to execution. We are now venturing towards building fully autonomous vehicles ready for city roads, developing electric vehicles and its associated charging infrastructure to creating shared mobility solutions with sustainability at its core.

That’s why Reuters Events are bringing together key strategists from Hyundai, General Motors, and Volkswagen for what is sure to be a must-listen webinar. Sign up for this free session on July 21st at 11am EDT now.

You will learn from:

  • Reinhard Fischer, Senior Vice President and North American Region Strategy, Volkswagen
  • Liran Golan, Head of Future Mobility, Hyundai Motors Europe
  • Jonathan Weinberger, Chief Advocate Global Transportation Technology, General Motors

Register now to listen in live or receive the recordings

Here are some key concepts you can expect to be addressed:

  • As technology takes over, hear how OEMs are preparing their business for a software-defined future that is tailored to the evolving expectations of the modern consumer.
  • How automotive tech has enabled the industry to delve into new safety features that outperform human error by minimizing the wrong decisions made on the road.
  • The importance of offering resilience and stability within your supply chain to ensure consistency on costs and affordability.
  • The need to explore and establish robust electrical infrastructure and charge points to meet the needs of a new generation of electric vehicles.

Unable to join us live? Not to worry, register for free here and we will send you the recordings after.

Let me know if you have any questions!

Best,
Nabil

Nabil Awan
Conference Producer
Automotive
Reuters Events
nabil.awan@thomsonreuters.com

Corporate Logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/127882

#distro

Posted on by

No adverse booster shot events found in LTC residents; vaccines potent against omicron, studies reveal

No adverse booster shot events found in LTC residents; vaccines potent against omicron, studies reveal



A study across 239 Genesis HealthCare nursing homes has found no evidence of adverse reactions to COVID-19 booster shots among residents. The news arrives alongside results from two new studies showing current booster efficacy against the omicron variant.

Investigators from Brown University and Genesis compared rates of adverse events between nursing home residents who had received an mRNA COVID-19 vaccine booster dose and their peers who had yet to receive a booster. The primary mRNA vaccine series was delivered at least six months before Sept. 22, 2021 and participants’ third booster doses were given between that date and February 2, 2022.  

“No safety signals were detected,” in a 14-day post-vaccination period, reported veteran nursing home researcher Vincent Mor Ph.D., and colleagues.

Quick immune response

Another study, published Thursday in the journal Nature, may help answer the question of how effective these boosters are against omicron. Study participants given three doses of an mRNA vaccine were able to quickly produce antibodies against the variant, researchers from The Rockefeller University in New York reported. 

“These data help explain why a third dose of a vaccine that was not specifically designed to protect against variants is effective against variant-induced serious disease,” they wrote.

A cohort study published Friday, meanwhile, has found a “persisting and robust” immune response to omicron mutations in patients with different vaccination histories. 

“The results mean that both vaccination and previous infection with COVID-19 likely prevent severe illness and death from the omicron strain,” reported the Center for Infectious Disease Research and Policy.

Related articles:

Third Pfizer booster dose has mild side effects